ST

SURGE Therapeutics

Biotechnology · Cambridge, Massachusetts, United States

About

They aim to create a world where all cancer patients undergoing surgical tumor resection can receive intraoperative immunotherapy to prevent post-surgical recurrence and metastasis.

Company details may include data from People Data Labs, licensed CC BY 4.0.